FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W54525483> ?p ?o ?g. }

• W54525483 abstract "The aims of this thesis were to investigate the pharmacokinetics and pharmacodynamics of non-steroidal anti-inflammatory drugs in birds. For decades, the inflammatory process and the properties of the NSAIDs have been extensively investigated in humans and other species. However, current knowledge on inflammation and anti-inflammatory drugs in birds is limited. Inflammation is a complex mechanism designed to protect the organism against different stimuli. NSAIDs act as inhibitors of the formation of certain mediators of inflammation, originating from the arachidonic acid cascade. In the general introduction, the literature is reviewed about the mechanism of action, the adverse reactions and the pharmacokinetics of non-steroidal anti-inflammatory drugs, and the possible indications for use of anti-inflammatory drugs in bird medicine. Due to the lack of information on NSAIDs in birds, most of the information about the mechanism of action and the adverse reactions are described based on the knowledge obtained in mammal species. In chapter 1.1., an overview about the main pharmacokinetic parameters and some bird specific anatomy and physiology is given. In chapter 2.1., the literature about the different aspects of inflammation in birds is reviewed: increased vascular permeability, leukocyte changes, acute phase proteins and inflammation mediators. On several occasions, a comparison with inflammation in mammals is made. Especially the acute phase of inflammation is described. Information on the pharmacokinetics of anti-inflammatory drugs in birds is scarce. Choice of drug and choice of dosage is usually empirical, since studies of antiinflammatory drugs are lacking. In chapter 1.2., the first experiments are described, three commonly used veterinary non-steroidal anti-inflammatory drugs (NSAIDs) were administered intravenously to five different bird species. Sodium salicylate, flunixin and meloxicam were selected as anti-inflammatory drugs. These NSAIDs were administered intravenously to chickens (Gallus gallus), ostriches (Struthio camelus), ducks (Cairina moshata), turkeys (Meleagris gallopavo) and pigeons (Columba livia). Plasma concentrations of the drugs were determined by validated high-performance liquid chromatography methods and pharmacokinetic parameters were calculated with compartment models. Also the plasma protein binding capacity of the different bird species for flunixin, meloxicam and salicylic acid at three different concentrations was studied. Most bird species exhibited a rapid elimination of these drugs. Ostriches had the fastest elimination rate for all three NSAIDs, but there were some interesting species differences. For salicylic acid, the half-life in pigeons was at least three to five times longer than the other bird species. Chickens had a half-life that was approximately ten times as long as the other bird species for flunixin and the half-life of meloxicam in chickens and pigeons was three times as long as for the other bird species. The plasma protein binding capacity for flunixin and meloxicam was moderate and showed a similar pattern for the different bird species. For salicylic acid more variation was seen between the species and pigeons exhibited a very low plasma protein binding capacity for salicylic acid. Several reasons for this difference in pharmacokinetic parameters are possible. Metabolism of these drugs can be species dependent. Therefore, the excretion pattern of sodium salicylate and its metabolites in chickens and pigeons was studied. This is described in chapter 1.3. An intravenous injection was made in these birds and the combined urinary and faecal droppings were collected at different time intervals. A marked difference was seen in the amino acid conjugation pattern of salicylic acid. Chickens used ornithine for conjugation and pigeons used glycine. Furthermore, the excretion of the glycine conjugate in pigeons was prolonged and in contrast to the ornithine conjugate in chickens, was not seen in the plasma. Based on preliminary information obtained in liver and kidney tissues of these species, it seems that the amino acid conjugation of salicylic acid with glycine in pigeons occurs only in the kidney and the amino acid conjugation of salicylic acid with ornithine in chickens occurs both in liver and in kidney. The pharmacodynamics of the NSAIDs in birds were studied in two inflammation models in chickens. In both models, sodium salicylate was used as NSAID, since this drug exhibited favourable pharmacokinetics in chickens and can be economically and practically interesting for use in poultry medicine. In chapter 2.2., an experiment where an acute inflammatory reaction was generated by implanting a carrageenan impregnated sponge strip in the subcutaneous tissue of broiler chickens is described. Half of the chickens received 50 mg/kg BW sodium salicylate orally and half received a placebo treatment. Blood and exudate samples were taken from these chickens at predetermined times. The pharmacokinetics of sodium salicylate were investigated in blood and exudate. Other parameters that were investigated were the volume of the exudate, the number of leukocytes in the exudate and the prostaglandin E2 concentration in the exudate. Also bradykinin was injected intradermally and the effects of sodium salicylate on bradykinin induced oedema were studied. Maximum salicylic acid plasma concentrations occurred within the hour after administration and maximum exudate levels were seen at the first exudate sampling point (4 h). Salicylic acid exudate concentrations exceeded plasma concentrations at the same time points and the exudate half-life was longer than the plasma half-life. No differences were found in the volume of the exudate and the leukocyte numbers between the treated and the untreated group. Sodium salicylate reduced the PGE2 concentration in the inflammatory exudate at the 4 hour time point, but at the later time points, no significant differences were found. The intradermally injected bradykinin did not produce significant effects in the chicken skin. Based on these findings, sodium salicylate may be used to suppress the inflammatory cascade in chickens, but further research is needed to characterise the inflammatory response in this chemical inflammation model and the actions of this non-steroidal antiinflammatory drug in chickens. In chapter 2.3., the last set of experiments are described. An acute phase reaction in broiler chickens was provoked through the intravenous injection of Escherichia coli lipopolysaccharide. Two experiments were set up with sodium salicylate to study the effects of this NSAID upon the LPS acute phase reaction. In the first experiment, different oral doses of sodium salicylate were given and the effect on body temperature was measured. Other inflammation indices, such as plasma corticosterone and ceruloplasmin levels, serum thromboxane B2 and zinc levels were also monitored during the experiment. In a separate experiment, food and water consumption and other behavioural parameters were studied. In the first experiment, a dose dependent attenuation of the fever response of the chickens in the salicylate treated groups was observed. Plasma corticosterone and ceruloplasmin levels rose and zinc and thromboxane B2 levels declined after an LPS injection. Except for thromboxane B2, no dose dependent differences after treatment with sodium salicylate were seen in these parameters. In the second experiment, the water intake, but not the food intake, was significantly higher in the salicylate treated group. No behavioural differences were seen between the positive control and the salicylate treated group. These data confirm that sodium salicylate is an effective antipyretic agent after injection of LPS in chickens, if used at an appropriate dosage. The general conclusions of this research after the pharmacokinetics and pharmacodynamics of NSAIDs in bird medicine are manifold : the investigated NSAIDs generally have a rapid half-life, but large species differences exist. The pharmacokinetics of other more practical administration routes need further research. The differences in metabolism may be a reason for the differences in pharmacokinetic parameters between the bird species. Salicylates have a clear antipyretic effect in chickens, but the mediation of avian inflammation and the influence of NSAIDs on disease and pain need further research." @default.
• W54525483 created "2016-06-24" @default.
• W54525483 creator A5076175106 @default.
• W54525483 date "2003-01-01" @default.
• W54525483 modified "2023-09-28" @default.
• W54525483 title "Pharmacokinetics and pharmacodynamics of non-steroidal anti-inflammatory drugs in birds" @default.
• W54525483 cites W130614201 @default.
• W54525483 cites W1543425313 @default.
• W54525483 cites W161150634 @default.
• W54525483 cites W181848942 @default.
• W54525483 cites W2014865291 @default.
• W54525483 cites W2015575587 @default.
• W54525483 cites W2021120688 @default.
• W54525483 cites W2023734146 @default.
• W54525483 cites W2033416081 @default.
• W54525483 cites W2040413712 @default.
• W54525483 cites W2040573668 @default.
• W54525483 cites W2041196142 @default.
• W54525483 cites W2043954540 @default.
• W54525483 cites W2063672987 @default.
• W54525483 cites W2067358058 @default.
• W54525483 cites W2070739446 @default.
• W54525483 cites W2076534794 @default.
• W54525483 cites W2076613740 @default.
• W54525483 cites W2076899914 @default.
• W54525483 cites W2078493251 @default.
• W54525483 cites W2080157228 @default.
• W54525483 cites W2083824460 @default.
• W54525483 cites W2086091678 @default.
• W54525483 cites W2087610126 @default.
• W54525483 cites W2088303951 @default.
• W54525483 cites W2088880591 @default.
• W54525483 cites W2094712550 @default.
• W54525483 cites W2102682430 @default.
• W54525483 cites W2128544718 @default.
• W54525483 cites W2155976295 @default.
• W54525483 cites W2157898327 @default.
• W54525483 cites W2172464059 @default.
• W54525483 cites W2268044829 @default.
• W54525483 cites W2297891003 @default.
• W54525483 cites W2325799778 @default.
• W54525483 cites W2341874593 @default.
• W54525483 cites W2409799216 @default.
• W54525483 cites W2412189609 @default.
• W54525483 cites W2414917340 @default.
• W54525483 cites W2434413813 @default.
• W54525483 cites W2435663345 @default.
• W54525483 cites W2583087416 @default.
• W54525483 cites W2593983566 @default.
• W54525483 cites W2603049366 @default.
• W54525483 cites W2626351064 @default.
• W54525483 cites W2712947300 @default.
• W54525483 hasPublicationYear "2003" @default.
• W54525483 type Work @default.
• W54525483 sameAs 54525483 @default.
• W54525483 citedByCount "0" @default.
• W54525483 crossrefType "dissertation" @default.
• W54525483 hasAuthorship W54525483A5076175106 @default.
• W54525483 hasConcept C111113717 @default.
• W54525483 hasConcept C112705442 @default.
• W54525483 hasConcept C71924100 @default.
• W54525483 hasConcept C98274493 @default.
• W54525483 hasConceptScore W54525483C111113717 @default.
• W54525483 hasConceptScore W54525483C112705442 @default.
• W54525483 hasConceptScore W54525483C71924100 @default.
• W54525483 hasConceptScore W54525483C98274493 @default.
• W54525483 hasLocation W545254831 @default.
• W54525483 hasOpenAccess W54525483 @default.
• W54525483 hasPrimaryLocation W545254831 @default.
• W54525483 hasRelatedWork W1978842330 @default.
• W54525483 hasRelatedWork W1985759058 @default.
• W54525483 hasRelatedWork W1993375589 @default.
• W54525483 hasRelatedWork W2011133706 @default.
• W54525483 hasRelatedWork W2019564380 @default.
• W54525483 hasRelatedWork W2027867890 @default.
• W54525483 hasRelatedWork W2036141627 @default.
• W54525483 hasRelatedWork W2062490670 @default.
• W54525483 hasRelatedWork W2075395848 @default.
• W54525483 hasRelatedWork W2076763552 @default.
• W54525483 hasRelatedWork W2087043787 @default.
• W54525483 hasRelatedWork W2118179181 @default.
• W54525483 hasRelatedWork W2125731088 @default.
• W54525483 hasRelatedWork W2139774748 @default.
• W54525483 hasRelatedWork W2339236009 @default.
• W54525483 hasRelatedWork W2401128671 @default.
• W54525483 hasRelatedWork W2416896956 @default.
• W54525483 hasRelatedWork W2597206377 @default.
• W54525483 hasRelatedWork W2799788731 @default.
• W54525483 hasRelatedWork W3106243005 @default.
• W54525483 isParatext "false" @default.
• W54525483 isRetracted "false" @default.
• W54525483 magId "54525483" @default.
• W54525483 workType "dissertation" @default.